Gemini Clinical Trial Site 11 — Campbell, California

Gemini Clinical Trial Site 11 is a clinical research site located in Campbell, California, United States 95008.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Gemini Clinical Trial Site 11 has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Sponsors: Gemini Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Campbell

Browse all research sites in California · View every site in Campbell

• El Camino Hospital
• Retinal Diagnostic Center
• Research Site
• Southbay Oncology Hematology Partners
• Aesthetx
• Family Eye Care Center
• South Bay Oncology Hematology Partners
• Silicon Valley Spine Institute
• Adverum Clinical Site 201
• Novartis Investigative Site
• Photozig, Inc.
• LGTC Group

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gemini Clinical Trial Site 11?

Gemini Clinical Trial Site 11 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gemini Clinical Trial Site 11 conducted?

Gemini Clinical Trial Site 11 has 1 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Is Gemini Clinical Trial Site 11 accredited by Crixeo Clinical Trials?

Gemini Clinical Trial Site 11 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gemini Clinical Trial Site 11?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.